EUGON XP 150IU INJECTION

Eugon XP 150IU Injection is a source of the active ingredient Menotrophin. Menotrophin is an ovarian stimulator and is part of the family of drugs known as gonadotropins. It is a pure mixture of follicle-stimulating hormone (FSH) and the luteinizing hormone (LH). They are both natural hormones created by both females and males. They usually assist the reproductive organs in working.
Eugon XP 150IU Injection is intended to address infertility for women who aren’t ovulating, have polycystic Ovarian Disease, and have not had a response to treatment using a medicine known as clomiphene. It also assists multiple follicles and, thus, promotes fertility among women undergoing IVF (in-vitro fertilization) or other forms that help in conception. It is also used to treat male infertility due to a lower sperm count.
Do not take Eugon XP150IU injection if you are sensitive to menotrophin or other medication ingredients. Don’t take this medication if you are suffering from an infiltrate of the pituitary gland (a gland that is located at the brain’s bottom that makes certain hormones which include growth hormones) or in the hypothalamus (an area that is located beneath the brain’s surface known as the thalamus that regulates the body’s conditions like your body’s temperature, blood pressure and even) and in ovaries, uterus, the testicles, and breasts or the prostate gland. Before you begin treatment, you’ll be examined for thyroid issues, hormone levels, and tumors in the hypothalamus and pituitary.
Don’t take this medicine if you suffer from cysts of the ovary that aren’t caused by PCOD vaginal bleeding or menopausal symptoms, problems with your organs of reproduction if your womb was removed, or if you are breastfeeding or pregnant. Contact your doctor immediately if you are experiencing any of these signs, including abdominal pain and swelling or diarrhea, weight gain or breathing problems, and a decrease in urination. Inform your doctor if you are suffering from or have been diagnosed with liver issues or had a history of blood clotting disease before starting treatment.